Nord/LB Reiterates €155.00 Price Target for Hannover Re (FRA:HNR1)

Share on StockTwits

Nord/LB set a €155.00 ($180.23) price objective on Hannover Re (FRA:HNR1) in a research report report published on Thursday, Borsen Zeitung reports. The brokerage currently has a neutral rating on the stock.

A number of other brokerages have also recently issued reports on HNR1. Barclays set a €123.10 ($143.14) target price on Hannover Re and gave the stock a sell rating in a report on Wednesday. Goldman Sachs Group set a €120.00 ($139.53) price target on Hannover Re and gave the company a sell rating in a report on Wednesday. UBS Group set a €150.00 ($174.42) price target on Hannover Re and gave the company a neutral rating in a report on Wednesday. Bankhaus Lampe set a €135.00 ($156.98) price target on Hannover Re and gave the company a neutral rating in a report on Wednesday. Finally, JPMorgan Chase & Co. set a €133.00 ($154.65) price target on Hannover Re and gave the company a sell rating in a report on Wednesday. Seven research analysts have rated the stock with a sell rating and nine have given a hold rating to the company. The company currently has an average rating of Hold and an average target price of €132.86 ($154.49).

Shares of HNR1 opened at €165.70 ($192.67) on Thursday. Hannover Re has a 1 year low of €94.75 ($110.17) and a 1 year high of €116.37 ($135.31). The stock has a 50 day simple moving average of €156.73 and a 200-day simple moving average of €144.87.

Hannover Re Company Profile

Hannover Rück SE, together with its subsidiaries, provides reinsurance products and services worldwide. It operates through Property & Casualty Reinsurance, and Life & Health Reinsurance segments. The Property & Casualty Reinsurance segment offers specialty lines comprising marine, aviation, facultative, credit, surety, and political risks reinsurance products; and treaty, catastrophe XL, and structured reinsurance, as well as insurance-linked securities.

See Also: Special Dividends

Analyst Recommendations for Hannover Re (FRA:HNR1)

Receive News & Ratings for Hannover Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hannover Re and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.